Literature DB >> 2523781

Lipids, diabetes, and vascular disease: the time to act.

D J Betteridge1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2523781     DOI： 10.1111/j.1464-5491.1989.tb01149.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  9 in total

1.  The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients.

Authors:  R W James; D Pometta
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

Review 2.  Triglycerides and disease.

Authors:  C A Seymour; C D Byrne
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

3.  Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association.

Authors:  D J Betteridge; P M Dodson; P N Durrington; E A Hughes; M F Laker; D P Nicholls; J A Rees; C A Seymour; G R Thompson; A F Winder
Journal:  Postgrad Med J       Date:  1993-05       Impact factor: 2.401

4.  Metabolic risk factors for cardiovascular disease in pancreas and kidney transplant recipients.

Authors:  G Nyberg; G Fager; L Mjörnstedt; M Olausson
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

5.  Doxazosin in the management of hypertensive diabetes--a cautionary note (?).

Authors:  B McLaughlin; L Daly; J G Devlin
Journal:  Ir J Med Sci       Date:  1992-01       Impact factor: 1.568

Review 6.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

7.  Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.

Authors:  F S Nielsen; A I Voldsgaard; M A Gall; P Rossing; E Hommel; P Andersen; J Dyerberg; H H Parving
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

8.  Asymptomatic coronary artery disease in diabetes: relation to common risk factors, lipoproteins, apoproteins and apo E polymorphism.

Authors:  M J Koistinen; H V Huikuri; U R Korhonen; M K Linnaluoto; T Kuusi; J T Takkunen; M R Taskinen
Journal:  Acta Diabetol       Date:  1994-12       Impact factor: 4.280

9.  Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles.

Authors:  L S Hermann; J E Karlsson; A Sjöstrand
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.